Cite
HARVARD Citation
Scailteux, L. et al. (2022). Hospitalization for adverse events under abiraterone or enzalutamide exposure in real‐world setting: A French population‐based study on prostate cancer patients. British journal of clinical pharmacology. 88 (1), pp. 336-346. [Online].